HomeNerviano Medical Sciences to present data on novel anticancer molecules at the AACR Annual Meeting 2012

Nerviano Medical Sciences to present data on novel anticancer molecules at the AACR Annual Meeting 2012

Nerviano, 01.03.2012

Nerviano Medical Sciences will disclose data on novel anticancer molecules at the AACR Annual Meeting 2012.

The presentations include:

Magnaghi, P et al: “Identification of potent VCP/p97/CDC48 inhibitors with distinct biochemical mechanisms including a reversible, allosteric inhibitor that activates the unfolded protein response, induce autophagy and cancer cell death”. Oral presentation. Abstract Number:  2940 Presentation Time: Monday, Apr 02, 2012, 3:20 PM - 3:35 PM

Pulici, M et al: “Characterization of NMS-P285, a new highly selective and potent BRAF inhibitor”. Abstract Number:  3754. Presentation Time: Tuesday, Apr 03, 2012, 8:00 AM -12:00 PM

Montagnoli, A et al: “Characterization of new highly selective and potent PARP-1 inhibitors”. Abstract Number:  1775. Presentation Time: Monday, Apr 02, 2012, 8:00 AM -12:00 PM